# Nans Tech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nans-tech

- Industry: Healthcare IT
- Headquarters: Hangzhou, China
- Website: www.nanstech.com
- Latest round: Series A (Dec 6, 2024)
- Investors on record: 4

## About

Established in 2019 and based in Hangzhou, China, Hangzhou Nansu Technology Co., Ltd., trading as Nans Tech, operates as a healthcare IT company that mainly provides digital therapy for pan-brain dysfunction. It was awarded the title of national-level science and technology-based small and medium-sized enterprise. In June 2026, Nans Tech raised a pre-series B funding led by Plum Ventures, with participation from Jiangxi Finance Holding.

The company mainly provides intelligent rehabilitation solutions for patients with pan-brain dysfunction. Products include Xiaonantingshuo, Speech and Language Assessment and Training System, Autism Digital Training System, Motor Assessment System, etc. Xiaonantingshuo is a digital therapy product for language disorders, suitable for language rehabilitation training for patients with speech and language disorders and cognitive disorders, and is mainly used by otolaryngology, rehabilitation, and neurology in medical institutions. The product is mainly aimed at rehabilitation treatment of patients with autism, cognitive disorders, ADHD, etc.

The company generates revenue by providing digital therapy products such as Xiaonantingshuo and a series of intelligent hardware systems.

## Funding rounds

- Series A, Dec 6, 2024 — Zhongxi Capital, Sichuan Zhenghexiang Health Pharmacy Chain Co., Ltd., Fangtian Education
- Series A, Dec 1, 2022 — Shulan Junjie Capital

## Investors

- Shulan Junjie Capital (https://capitalatlas.ai/funds/shulan-junjie-capital) — Series A
- Zhongxi Capital (https://capitalatlas.ai/funds/zhongxi-capital) — Series A
- Sichuan Zhenghexiang Health Pharmacy Chain Co., Ltd. — Series A
- Fangtian Education — Series A